 David Ewing Duncan, Chief Correspondent of NPR Talk’s “Biotech Nation” and best-selling Author, “Masterminds”
|
 James A. Wells, Ph.D., Professor and Chair of Pharmaceutical Chemistry, and Professor of Cellular & Molecular Pharmacology, University of California, San Francisco |
 Jay M.
Tenenbaum, Ph.D., Chairman and Chief Scientist,
CollabRx, Inc. |
 Michael J.
Yaszemski, Ph.D., M.D., Brigadier General, United States Air Force, Professor, Orthopedic
Surgery and Biomedical Engineering, Mayo Clinic College of Medicine
|
 Daniel H.
Farkas, Ph.D., HCLD, Executive Director, Center for
Molecular Medicine |
 Steve Shak, M.D., Chief Medical Officer,
Genomic Health Inc. |
 William J. Rutter, Ph.D., Chairman, Synergenics LLC |
 John A. Todd, Ph.D., University Chair, Medical Genetics, University of Cambridge |
|
Session Topics Include
Success Stories of Novel Test Adoption
Development of Diagnostics for Standard of Care
Implementing Novel Technologies
Point-of-Care Market Outlook and Technical Development
Breakout Discussion Groups
-
Overcoming Integration Hurdles for Rapid Testing
-
Value-Based Pricing for Molecular Diagnostics
-
Preventative Genomic Medicine
-
Stakeholders for Companion Diagnostics
-
Future of Point-of-Care Testing
Panel Discussions
VC PANEL: How is personalized medicine moving forward?
MEDICAL PANEL: Future of point-of-care
BUSINESS PANEL: Global trends in molecular diagnostics
|
